Vertex Stock Flashes Buy Signal; Gene-Editing Play Leads 5 Resilient Stocks In Bear Market

Gene-editing company Vertex Pharmaceuticals (VRTX) and entertainment giant WWE (WWE) lead the five stocks to watch for the week ahead. Cardinal Health (CAH), Cameco (CCJ) and Carlisle (CSL) round out ...

CRSP Stock: The First CRISPR Gene-Editing Drug Could Be Here Sooner Than You Think

Crispr Therapeutics (CRSP) said Tuesday it will begin asking the Food and Drug Administration to approve what would be the first-ever gene-editing treatment to hit the market using the CRISPR technolo...

Cathie Wood Loads Up $23M In Gene-Editing Company’s Shares

Ark’s actively managed funds will continue to be managed by Cathie Wood, who will retain her position as chief executive Verve is the 12th largest holding in the ARK ETF  William Scherer has been appo...

Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success

Text size Intellia CEO John Leonard called the results a vindication of the company’s modular approach to Crispr therapies. Courtesy Intellia Therapeutics Patients who got a one-time gene-editin...

Cathie Wood Watch: Buys Tesla, Roku, Coinbase, Gene-Editing Firm

Renowned investor Cathie Wood, chief executive of Ark Investment Management, on May 25 bought and sold some familiar names. All valuations below are as of Thursday’s close. For the third straight day,...